The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2022 | The impact of COVID-19 on lung cancer surgery
Paul Van Schil, MD, PhD, University Hospital Antwerp (UZA), Edegem, Belgium discusses the impact of COVID-19 on lung cancer surgery. Although there were limited operating times during this time period, patients with lung cancer were prioritized for surgery and operations were not postponed unless infected with COVID-19. This interview took place during the virtual European Lung Cancer Congress 2022.
